Page last updated: 2024-08-23

bezafibrate and Liver Diseases, Alcoholic

bezafibrate has been researched along with Liver Diseases, Alcoholic in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Banerjee, A; Lee, JH; Ramaiah, SK; Ueno, Y1
Dou, X; Gu, D; Li, S; Shen, C; Song, Z; Wang, Z; Yao, T1
Barve, S; Bradford, BU; Chawla, RK; Colell, A; Deaciuc, I; Enomoto, N; Fernandez-Checa, JC; Garcia-Ruiz, C; Hill, D; Hirose, M; Ikejima, K; Ishii, H; Ishikawa, M; Joshi-Barve, S; Kaplowitz, N; Kitamura, T; Konno, A; Kono, H; Lin, M; McClain, CJ; Motomura, K; Nakamura, Y; Nelson, W; Ohata, M; Oide, H; Okamura, Y; Peter, S; Rivera, CA; Sato, N; Schmidt, J; Shimizu, H; Takei, Y; Thurman, R; Tsukamoto, H; Watson, W; Yamashina, S; Yokoyama, H1

Reviews

1 review(s) available for bezafibrate and Liver Diseases, Alcoholic

ArticleYear
How is the liver primed or sensitized for alcoholic liver disease?
    Alcoholism, clinical and experimental research, 2001, Volume: 25, Issue:5 Suppl IS

    Topics: Animals; Bezafibrate; Endotoxins; Gene Expression; Hepatocytes; Humans; Hypolipidemic Agents; Iron; Kupffer Cells; Liver; Liver Diseases, Alcoholic; Mitochondria, Liver; Peroxisome Proliferators; S-Adenosylmethionine; Superoxides; Tretinoin; Tumor Necrosis Factor-alpha

2001

Other Studies

2 other study(ies) available for bezafibrate and Liver Diseases, Alcoholic

ArticleYear
Potential relationship between hepatobiliary osteopontin and peroxisome proliferator-activated receptor alpha expression following ethanol-associated hepatic injury in vivo and in vitro.
    Toxicological sciences : an official journal of the Society of Toxicology, 2008, Volume: 106, Issue:1

    Topics: Acetaldehyde; Animals; Bezafibrate; Bile Ducts; Cell Line, Tumor; Disease Models, Animal; Epithelial Cells; Ethanol; Hepatocytes; Humans; Lipopolysaccharides; Liver; Liver Diseases, Alcoholic; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Osteopontin; PPAR alpha; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transcription, Genetic; Transfection

2008
Inhibition of NF-κB activation by 4-hydroxynonenal contributes to liver injury in a mouse model of alcoholic liver disease.
    The American journal of pathology, 2012, Volume: 181, Issue:5

    Topics: Acetylcysteine; Aldehydes; Animals; Bezafibrate; Caspases; Cell Death; Cytoprotection; Disease Models, Animal; Enzyme Activation; Ethanol; Hep G2 Cells; Hepatocytes; Humans; I-kappa B Proteins; JNK Mitogen-Activated Protein Kinases; Liver; Liver Diseases, Alcoholic; Male; Mice; Mice, Inbred C57BL; NF-kappa B; NF-KappaB Inhibitor alpha; Phosphorylation; Time Factors; Transcriptional Activation; Tumor Necrosis Factor-alpha

2012